ALT
USDAltimmune Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$3.920
High
$4.160
Low
$3.775
Volume
2.59M
Company Fundamentals
Market Cap
428.8M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.84M
Exchange
NGM
Currency
USD
52-Week Range
Related News
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
Enrollment completed ahead of schedule, underscoring strong interest from patient community in a potential new therapeutic option On track to complete the 24-week treatment period and announce topline results in 2026
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera has become the obesity drug market's hottest ticket.
Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases,
Related Stocks
HIE
Miller/Howard High Income Equity Fund Common Shares of Beneficial Interest
PECO
Phillips Edison & Company Inc.
HD
Home Depot Inc. (The)
EVER
EverQuote Inc.
PWUPU
PowerUp Acquisition Corp. Unit
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.